◆英語タイトル：Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3294
◆発行会社（調査会社）：
MarketLine
◆発行日：2019年11月
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
Immunogen, Inc. – Strategy, SWOT and Corporate Finance Report
Summary
Immunogen, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
ImmunoGen, Inc. (ImmunoGen or ‘the company’) is a developer of targeted anticancer therapeutics using its antibody-drug conjugate (ADC) technology. The ADC technology is comprised of the company’s portfolio of cancer-cell killing agents that can be attached to antibodies for targeted delivery to cancer cells. The major suppliers of the company include Boehringer Ingelheim, Catalent Pharma Solutions, LLC, Rentschler Biotechnologie GmbH, Carbogen Amcis, BSP Pharmaceuticals S.r.l., SAFC, Inc., and Società Italiana Corticosteroidi S.r.l. Some collaborative partners of the company like Amgen, Bayer, CytomX, Biotest, Lilly, Novartis, the Roche Group, Sanofi and Takeda uses the company’s ADC technology to develop anticancer therapies. ImmunoGen is headquartered in Waltham, Massachusetts, the US.
Scope
- Detailed information on Immunogen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Immunogen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Immunogen, Inc. including a breakdown and examination of key business segments
- Intelligence on Immunogen, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Immunogen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Immunogen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Immunogen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Immunogen, Inc.’s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Table of Contents
ImmunoGen, Inc.: Company Overview
ImmunoGen, Inc.: Overview and Key Facts
ImmunoGen, Inc.: Overview
ImmunoGen, Inc.: Key Facts
ImmunoGen, Inc.: Key Employees
ImmunoGen, Inc.: Key Employee Biographies
ImmunoGen, Inc.: Major Products and Services
ImmunoGen, Inc.: Company History
ImmunoGen, Inc.: Management Statement
ImmunoGen, Inc.: Key Competitors
ImmunoGen, Inc.: Company Analysis
ImmunoGen, Inc.: Business Description
ImmunoGen, Inc.: SWOT Analysis
ImmunoGen, Inc.: SWOT Overview
ImmunoGen, Inc.: Strengths
ImmunoGen, Inc.: Weaknesses
ImmunoGen, Inc.: Opportunities
ImmunoGen, Inc.: Threats
ImmunoGen, Inc.: Corporate Financial Deals Activity
ImmunoGen, Inc.: Financial Deals Overview
ImmunoGen, Inc.: Targets and Partners
ImmunoGen, Inc.: Top Deals 2015 – 2019YTD*
ImmunoGen, Inc.: Advisors
ImmunoGen, Inc.: Top Legal Advisors
ImmunoGen, Inc.: Top Financial Advisors
ImmunoGen, Inc.: Capital Raising
ImmunoGen, Inc.: Partnership
ImmunoGen, Inc.: Divestments
ImmunoGen, Inc.: Recent Developments
ImmunoGen, Inc.: News and Events Summary
ImmunoGen, Inc.: Business Expansion
ImmunoGen, Inc.: Business Reorganization
ImmunoGen, Inc.: Corporate Governance
ImmunoGen, Inc.: Financial Performance
ImmunoGen, Inc.: Market Developments
ImmunoGen, Inc.: Red Flags/DistressSignals
ImmunoGen, Inc.: Research & Development
ImmunoGen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: ImmunoGen, Inc.: Key Facts
Table 2: ImmunoGen, Inc.: Key Employees
Table 3: ImmunoGen, Inc.: Company History
Table 4: ImmunoGen, Inc.: Key Competitors
Table 5: ImmunoGen, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 6: ImmunoGen, Inc.: Targets and Partners
Table 7: ImmunoGen, Inc.: Top Deals 2015 - 2019YTD*
Table 8: ImmunoGen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 9: ImmunoGen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: ImmunoGen, Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 11: ImmunoGen, Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Table 12: ImmunoGen, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 13: ImmunoGen, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 14: ImmunoGen, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 15: ImmunoGen, Inc.: News and Events Summary
Table 16: ImmunoGen, Inc.: Business Expansion
Table 17: ImmunoGen, Inc.: Business Reorganization
Table 18: ImmunoGen, Inc.: Corporate Governance
Table 19: ImmunoGen, Inc.: Financial Performance
Table 20: ImmunoGen, Inc.: Market Developments
Table 21: ImmunoGen, Inc.: Red Flags/DistressSignals
Table 22: ImmunoGen, Inc.: Research & Development
Table 23: ImmunoGen, Inc.: Strategy and Operations
